Modification of the effect of smoking on cholesterol in Japanese carriers of a PTPN11 polymorphism

Molecular Medicine Reports

Volumn 1, Issue 4, 2008, Pages 595-598

  Okada, Rieko ^a   Suzuki, Koji ^b   Nishio, Kazuko ^a   Ishida, Yoshiko ^a   Kawai, Sayo ^a   Goto, Yasuyuki ^a   Naito, Mariko ^a   Wakai, Kenji ^a   Ito, Yoshinori ^a   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Genetic polymorphism; HDL cholesterol; LDL cholesterol; PTPN11; Smoking; Src homology 2 domain containing protein tyrosine phosphatase 2

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN TYROSINE PHOSPHATASE SHP 2; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CIGARETTE SMOKING; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; JAPANESE; LIPID BLOOD LEVEL; MALE; MEDICAL EXAMINATION; NORMAL HUMAN; PROTEIN SECRETION; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 69249131728     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.4.595     Document Type: Article

References (20)

1. Craig WY, Palomaki GE and Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298: 784-788, 1989.
2. Hozawa A, Folsom AR, Sharrett AR, Payne TJ and Chambless LE: Does the impact of smoking on coronary heart disease differ by low-density lipoprotein cholesterol level?: the Atherosclerosis Risk in Communities (ARIC) Study. Circ J 70: 1105-1110, 2006.
3. Gabriel HE, Crott JW, Ghandour H, et al: Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 83: 835-841, 2006. (Pubitemid 44713148)
4. Philibert RA, Sandhu H, Hollenbeck N, Gunter T, Adams W and Madan A: Transcriptional profiling of subjects from the Iowa adoption studies. Am J Med Genet B Neuropsychiatr Genet 144: 683-690, 2007. (Pubitemid 47077154)
5. Costanza MC, Cayanis E, Ross BM, Flaherty MS, Alvin GB, Das K and Morabia A: Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population. Am J Epidemiol 161: 714-724, 2005. (Pubitemid 40503451)
6. Czerwinski SA, Mahaney MC, Rainwater DL, Vandeberg JL, MacCluer JW, Stern MP and Blangero J: Gene by smoking interaction: evidence for effects on low-density lipoprotein size and plasma levels of triglyceride and high-density lipoprotein cholesterol. Hum Biol 76: 863-876, 2004.
7. Morabia A, Cayanis E, Costanza MC, et al: Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors. Hum Mol Genet 12: 2733-2743, 2003. (Pubitemid 37407110)
8. Tiganis T and Bennett AM: Protein tyrosine phosphatase function: the substrate perspective. Biochem J 402: 1-15, 2007. (Pubitemid 46254902)
9. Phung TL, Roncone A, Jensen KL, Sparks CE and Sparks JD: Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J Biol Chem 272: 30693-30702, 1997. (Pubitemid 27527502)
10. Au WS, Kung HF and Lin MC: Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. Diabetes 52: 1073-1080, 2003.
11. Ugi S, Maegawa H, Kashiwagi A, Adachi M, Olefsky JM and Kikkawa R: Expression of dominant negative mutant SHPTP2 attenuates phosphatidylinositol 3′-kinase activity via modulation of phosphorylation of insulin receptor substrate-1. J Biol Chem 271: 12595-12602, 1996. (Pubitemid 26160934)
12. Jamshidi Y, Gooljar SB, Snieder H, et al: SHP-2 and PI3-kinase genes PTPN11 and PIK3R1 may influence serum apoB and LDL cholesterol levels in normal women. Atherosclerosis 194: e26-e33, 2007. (Pubitemid 47516675)
13. Friedewald WT, Levy RI and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
14. Hamajima N, Saito T, Matsuo K, Kozaki K, Takahashi T and Tajima K: Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 91: 865-868, 2000. (Pubitemid 30774558)
15. Goto Y, Ando T, Yamamoto K, Tamakoshi A, El-Omar E, Goto H and Hamajima N: Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer 118: 203-208, 2006. (Pubitemid 41681600)
16. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE and Moons KG: Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 56: 441-447, 2003.
17. Burkart A, Samii B, Corvera S and Shpetner HS: Regulation of the SHP-2 tyrosine phosphatase by a novel cholesterol- and cell confluence-dependent mechanism. J Biol Chem 278: 18360-18367, 2003. (Pubitemid 36799457)
18. Choudhury SR, Ueshima H, Kita Y, et al: Alcohol intake and serum lipids in a Japanese population. Int J Epidemiol 23: 940-947, 1994. (Pubitemid 24331208)
19. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M and Hatakeyama M: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295: 683-686, 2002. (Pubitemid 34111828)
20. Kawai S, Goto Y, Ito LS, et al: Significant association between PTPN11 polymorphism and gastric atrophy among Japanese Brazilians. Gastric Cancer 9: 277-283, 2006. (Pubitemid 44846550)